S&P ASX All Technology

US Dollar vs AUD

Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.

Get Started

ALIM Alimera Sciences Inc

3.05

-0.10 (-3.17%)

01 Jun 2024 - Closed

Delayed by 15 minutes

Form 3 - Initial statement of beneficial ownership of securities

Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From May 2024 to Jun 2024

Click Here for more Alimera Sciences Charts.

Alimera Sciences (NASDAQ:ALIM)
Historical Stock Chart
From Jun 2023 to Jun 2024

Click Here for more Alimera Sciences Charts.

Alimera Sciences Inc News

Form SC 13D/A - General statement of acquisition of beneficial ownership: [Amend]
Friday 17 May 2024 (2 weeks ago) • Edgar (US Regulatory)

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Wednesday 15 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Form 8-K - Current report
Tuesday 14 May 2024 (3 weeks ago) • Edgar (US Regulatory)

Alimera Sciences Reports First Quarter 2024 Results
Tuesday 14 May 2024 (3 weeks ago) • GlobeNewswire Inc.

Alimera Announces Scientific Data Highlighting YUTIQ® to be Presented at Upcoming Association for Research in Vision and Ophthalmology and Retina World Congress Conferences
Tuesday 7 May 2024 (4 weeks ago) • GlobeNewswire Inc.

Alimera Sciences to Report First Quarter 2024 Financial Results on May 14, 2024, and Provide Corporate Update
Tuesday 30 April 2024 (1 month ago) • GlobeNewswire Inc.

Alimera Sciences Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Wednesday 20 March 2024 (2 months ago) • GlobeNewswire Inc.

Alimera Announces First Patient Randomized in Radiation Retinopathy Trial Being Conducted by the DRCR Retina Network
Tuesday 19 March 2024 (2 months ago) • GlobeNewswire Inc.

Form S-8 - Securities to be offered to employees in employee benefit plans
Saturday 9 March 2024 (3 months ago) • Edgar (US Regulatory)

Form 8-K - Current report
Friday 8 March 2024 (3 months ago) • Edgar (US Regulatory)

Alimera Sciences Reports Fourth Quarter and Full Year 2023 Results
Thursday 7 March 2024 (3 months ago) • GlobeNewswire Inc.

Alimera Sciences to Report Fourth Quarter and Full Year 2023 Financial Results on March 7, 2024, and Provide Corporate Update
Friday 1 March 2024 (3 months ago) • GlobeNewswire Inc.

More Alimera Sciences Inc News Articles

National Australia Bank

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions